CCM
AMPE

Condor Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Condor Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-71
Closed -$47K – 169
2018
Q2 		$47K Hold
71
– – 0.01% 165
2018
Q1 		$73K Hold
71
– – 0.02% 163
2017
Q4 		$87K Buy
+71
New +$33.4K 0.02% 162

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Condor Capital Management's AMPE Position: Q3 2018 in Review

Condor Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2018, closing a stake of 71 shares — an estimated $47K sold.

Condor Capital Management first reported a position in AMPE in Q4 2017 and held it in 3 quarters. The position peaked at $87K in Q4 2017. 81 funds tracked by Wall St. Rank hold AMPE as of Q3 2018.

  • Condor Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Condor Capital Management sold 71 Ampio Pharmaceuticals Inc. shares in Q3 2018, an estimated $47K.
  • Condor Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2017 and held it in 3 quarters.
  • Condor Capital Management's Ampio Pharmaceuticals Inc. position peaked at $87K in Q4 2017.
  • 81 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2018.

Based on Condor Capital Management's 13F filing for Q3 2018, filed 1 Nov 2018.